Our Products

In September 2017, we received FDA approval for XHANCE (fluticasone propionate). Please see Instructions for Use, Important Safety Information, and full Prescribing Information at www.XHANCE.com.

ONZETRA® Xsail® (sumatriptan nasal powder), licensed to Avanir Pharmaceuticals, Inc., an affiliate of Otsuka Pharmaceutical Co., Ltd., has been approved for the delivery of low-dose sumatriptan using an Optinose Bi-Directional™ Exhalation Delivery System. See Instructions for Use, Important Safety Information, and full Prescribing Information at www.ONZETRAHCP.com.